CY1105676T1 - Basb029 πολυνουκλεοτιδιο (πολυνουκλεοτιδια) και πολυπεπτιδια απο neisseria meningitidis - Google Patents

Basb029 πολυνουκλεοτιδιο (πολυνουκλεοτιδια) και πολυπεπτιδια απο neisseria meningitidis

Info

Publication number
CY1105676T1
CY1105676T1 CY20061100057T CY061100057T CY1105676T1 CY 1105676 T1 CY1105676 T1 CY 1105676T1 CY 20061100057 T CY20061100057 T CY 20061100057T CY 061100057 T CY061100057 T CY 061100057T CY 1105676 T1 CY1105676 T1 CY 1105676T1
Authority
CY
Cyprus
Prior art keywords
polypeptides
neisseria meningitidis
basb029
basb029 polynucleotide
polynucleotide
Prior art date
Application number
CY20061100057T
Other languages
Greek (el)
English (en)
Inventor
Jean-Louis Ruelle
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10831992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1105676(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of CY1105676T1 publication Critical patent/CY1105676T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
CY20061100057T 1998-05-13 2006-01-17 Basb029 πολυνουκλεοτιδιο (πολυνουκλεοτιδια) και πολυπεπτιδια απο neisseria meningitidis CY1105676T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810276.7A GB9810276D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003255 WO1999058683A2 (en) 1998-05-13 1999-05-07 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)

Publications (1)

Publication Number Publication Date
CY1105676T1 true CY1105676T1 (el) 2010-12-22

Family

ID=10831992

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100057T CY1105676T1 (el) 1998-05-13 2006-01-17 Basb029 πολυνουκλεοτιδιο (πολυνουκλεοτιδια) και πολυπεπτιδια απο neisseria meningitidis

Country Status (23)

Country Link
US (3) US6780419B1 (https=)
EP (2) EP1621623A3 (https=)
JP (2) JP4707832B2 (https=)
KR (4) KR20080070073A (https=)
CN (1) CN1322127C (https=)
AT (1) ATE311457T1 (https=)
AU (1) AU750032B2 (https=)
BR (1) BR9910396A (https=)
CA (1) CA2328403C (https=)
CY (1) CY1105676T1 (https=)
CZ (1) CZ299612B6 (https=)
DE (1) DE69928658T2 (https=)
DK (1) DK1078063T3 (https=)
ES (1) ES2252946T3 (https=)
GB (1) GB9810276D0 (https=)
HU (1) HUP0102479A3 (https=)
IL (2) IL139613A0 (https=)
NO (2) NO326994B1 (https=)
NZ (1) NZ508323A (https=)
PL (1) PL197449B1 (https=)
TR (1) TR200003347T2 (https=)
WO (1) WO1999058683A2 (https=)
ZA (1) ZA200006523B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
EP1047784B2 (en) † 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
CA2371994C (en) 1999-02-26 2010-09-28 Guido Grandi Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
JP2004508801A (ja) 1999-10-29 2004-03-25 カイロン　ソチエタ　ア　レスポンサビリタ　リミタータ ナイセリア抗原性ペプチド
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
PT2289545T (pt) * 2000-01-17 2016-09-06 Glaxosmithkline Biologicals Sa Vacina de omv suplementada contra meningococos
NZ520445A (en) * 2000-01-25 2004-02-27 Univ Queensland Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
NZ521531A (en) 2000-02-28 2005-12-23 Chiron S Heterologous expression of neisserial proteins
ATE469915T1 (de) 2001-07-27 2010-06-15 Novartis Vaccines & Diagnostic Antikörper gegen das meningokokken adhäsin app
US20060057160A1 (en) 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
NZ546430A (en) 2003-10-02 2009-04-30 Novartis Vaccines & Diagnostic Liquid vaccines for multiple meningococcal serogroups
US7459930B2 (en) * 2006-11-14 2008-12-02 Micron Technology, Inc. Digital calibration circuits, devices and systems including same, and methods of operation
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0916570D0 (en) 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
WO2011110655A2 (en) 2010-03-11 2011-09-15 Glaxosmithkline Biologicals S.A. Vaccine
ES2642184T3 (es) * 2012-01-05 2017-11-15 Deutsches Krebsforschungszentrum Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H
WO2018022031A1 (en) 2016-07-27 2018-02-01 Prysmian S.P.A. Flexible optical-fiber ribbon

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
RU2023448C1 (ru) 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
EP1047784B2 (en) * 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
WO2000066741A2 (en) * 1999-04-30 2000-11-09 Chiron S.P.A. Conserved neisserial antigens

Also Published As

Publication number Publication date
NO326994B1 (no) 2009-03-30
WO1999058683A3 (en) 2000-04-06
TR200003347T2 (tr) 2001-06-21
NO20090955L (no) 2001-01-11
ATE311457T1 (de) 2005-12-15
NO20005696D0 (no) 2000-11-10
DK1078063T3 (da) 2006-04-03
BR9910396A (pt) 2001-10-30
DE69928658T2 (de) 2006-06-14
NZ508323A (en) 2002-10-25
EP1078063B1 (en) 2005-11-30
CZ20004202A3 (en) 2001-05-16
US6780419B1 (en) 2004-08-24
CZ299612B6 (cs) 2008-09-17
NO20005696L (no) 2001-01-11
JP2010166921A (ja) 2010-08-05
CN1322127C (zh) 2007-06-20
AU750032B2 (en) 2002-07-11
HK1036300A1 (en) 2001-12-28
US20040265332A1 (en) 2004-12-30
JP2002514424A (ja) 2002-05-21
EP1078063A2 (en) 2001-02-28
IL139613A0 (en) 2002-02-10
IL139613A (en) 2014-03-31
PL197449B1 (pl) 2008-03-31
KR20080070073A (ko) 2008-07-29
EP1621623A3 (en) 2009-02-18
HUP0102479A2 (hu) 2001-10-28
KR100673674B1 (ko) 2007-01-23
ZA200006523B (en) 2001-11-12
HUP0102479A3 (en) 2004-10-28
ES2252946T3 (es) 2006-05-16
EP1621623A2 (en) 2006-02-01
WO1999058683A2 (en) 1999-11-18
AU4142099A (en) 1999-11-29
GB9810276D0 (en) 1998-07-15
KR20060076789A (ko) 2006-07-04
PL345281A1 (en) 2001-12-03
JP4707832B2 (ja) 2011-06-22
CN1309707A (zh) 2001-08-22
CA2328403A1 (en) 1999-11-18
CA2328403C (en) 2013-11-05
US20090093622A1 (en) 2009-04-09
KR100897951B1 (ko) 2009-05-18
KR20100019461A (ko) 2010-02-18
DE69928658D1 (de) 2006-01-05
KR20010043571A (ko) 2001-05-25
WO1999058683A9 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
CY1105676T1 (el) Basb029 πολυνουκλεοτιδιο (πολυνουκλεοτιδια) και πολυπεπτιδια απο neisseria meningitidis
CY1113109T1 (el) Νεες ενωσεις
CY1109812T1 (el) Αντιγονικα πολυπεπτιδια neisseira meningitidis (μηνιγγιτιδοκοκκου), αντιστοιχα πολυνουκλεοτιδια και προστατευτικα αντισωματα
PL345793A1 (en) Neisseria meningitidis
PT1112366E (pt) Polinucleotideos e polipeptideos basb033 da neisseria meningitidis e suas utilizacoes
CY1105820T1 (el) Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις
CY1108554T1 (el) Ανοσογονικα πολυπεπτιδια που λαμβανονται απο moraxella catarrhalis και χρησεις αυτων
DE60134253D1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
CY1106060T1 (el) Basb11 πολυπεπτιδιο και πολυνουκλεοτιδιο απο moraxella catharrhalis
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
ATE527360T1 (de) Neue verbindungen abgeleitet von neisseria meningitidis
GB9918208D0 (en) Novel compounds
AU2002223598A1 (en) Polypeptide from haemophilus influenza
HK1042515A1 (zh) 來自腦膜炎球菌的basb055多核苷酸和多肽，其使用法
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
ATE515511T1 (de) Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen
ATE293692T1 (de) Moraxella catarrhalis antigen basb120
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis